Risperidone-induced fecal incontinence: A case report

Creative Commons License

Aygun B., Karayagmurlu A., Ustun N. S. G.

DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, vol.35, no.1, pp.56-58, 2022 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.14744/dajpns.2022.00172
  • Journal Name: DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Psycinfo, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.56-58
  • Keywords: Adverse effect, children, fecal incontinence, risperidone, ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, ENCOPRESIS, CHILD
  • Open Archive Collection: AVESIS Open Access Collection
  • Istanbul University Affiliated: Yes

Abstract

Fecal incontinence is defined as the inability to postpone or control the defecation requirement until socially convenient. There are many effective factors in its etiology. Drugs used in the treatment are one of these etiologic factors. Risperidone is an atypical antipsychotic with an antagonistic effect on dopamine 2 (D2) and serotonin 2A (5-HT2A) receptors and shows an affinity for noradrenaline alpha 1 and alpha 2 receptors. Risperidone is an effective and safe agent used in children and adolescents with psychiatric disorders such as oppositional defiant disorder (ODD) and conduct disorder. Fecal incontinence is an uncommon side effect of risperidone use. This report presents a 13-year-old patient with attention deficit hyperactivity disorder and ODD who developed fecal incontinence after dose increase due to risperidone treatment. This case is presented because there is a low number of case reports on risperidone-induced fecal incontinence in the literature.